Lisata Therapeutics (LSTA) Leases (2016 - 2025)
Lisata Therapeutics (LSTA) has disclosed Leases for 7 consecutive years, with $47000.0 as the latest value for Q2 2025.
- For the quarter ending Q2 2025, Leases fell 79.11% year-over-year to $47000.0, compared with a TTM value of $47000.0 through Jun 2025, down 79.11%, and an annual FY2024 reading of $138000.0, down 55.19% over the prior year.
- Leases was $47000.0 for Q2 2025 at Lisata Therapeutics, down from $93000.0 in the prior quarter.
- Across five years, Leases topped out at $425000.0 in Q1 2023 and bottomed at $47000.0 in Q2 2025.
- Average Leases over 3 years is $242000.0, with a median of $246000.0 recorded in 2024.
- The sharpest move saw Leases plummeted 37.18% in 2024, then plummeted 79.11% in 2025.
- Year by year, Leases stood at $308000.0 in 2023, then plummeted by 55.19% to $138000.0 in 2024, then tumbled by 65.94% to $47000.0 in 2025.
- Business Quant data shows Leases for LSTA at $47000.0 in Q2 2025, $93000.0 in Q1 2025, and $138000.0 in Q4 2024.